79 related articles for article (PubMed ID: 15648779)
1. Morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma.
Brown RE
Ann Clin Lab Sci; 2004; 34(4):397-9. PubMed ID: 15648779
[TBL] [Abstract][Full Text] [Related]
2. Morphoproteomics and bortezomib/dexamethasone-induced response in relapsed acute lymphoblastic leukemia.
Brown RE; Bostrom B; Zhang PL
Ann Clin Lab Sci; 2004; 34(2):203-5. PubMed ID: 15228234
[TBL] [Abstract][Full Text] [Related]
3. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
4. Brief communication: morphoproteomic analysis of osteolytic Langerhans cell histiocytosis with therapeutic implications.
Brown RE
Ann Clin Lab Sci; 2005; 35(2):131-6. PubMed ID: 15943175
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications.
Brown RE; Boyle JL
Ann Clin Lab Sci; 2003; 33(2):131-41. PubMed ID: 12817616
[TBL] [Abstract][Full Text] [Related]
6. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
Brown RE; Zhang PL; Lun M; Zhu S; Pellitteri PK; Riefkohl W; Law A; Wood GC; Kennedy TL
Ann Clin Lab Sci; 2006; 36(3):273-82. PubMed ID: 16951268
[TBL] [Abstract][Full Text] [Related]
7. Primary extraskeletal mesenchymal chondrosarcoma in fossa poplitea of a 93-year-old woman.
Guschmann M; Melcher I
Gen Diagn Pathol; 1996 Oct; 142(2):119-24. PubMed ID: 8950579
[TBL] [Abstract][Full Text] [Related]
8. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates.
Brown RE; Tan D; Taylor JS; Miller M; Prichard JW; Kott MM
Ann Clin Lab Sci; 2007; 37(2):141-7. PubMed ID: 17522369
[TBL] [Abstract][Full Text] [Related]
9. Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients.
Brown RE
Expert Rev Proteomics; 2005 Jun; 2(3):337-48. PubMed ID: 16000081
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathology analysis of mesenchymal chondrosarcoma in soft tissue].
Cai L; Gao ZF; Huang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):501-5. PubMed ID: 17068623
[TBL] [Abstract][Full Text] [Related]
11. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma.
Gatter KM; Olson S; Lawce H; Rader AE
Cancer Genet Cytogenet; 2005 Jun; 159(2):151-4. PubMed ID: 15899388
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal chondrosarcoma of the cerebellum.
Malik SN; Farmer PM; Hajdu SI; Rosenthal A
Ann Clin Lab Sci; 1996; 26(6):496-500. PubMed ID: 8908319
[TBL] [Abstract][Full Text] [Related]
14. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
Lin F; Zhang PL; Yang XJ; Prichard JW; Lun M; Brown RE
Ann Clin Lab Sci; 2006; 36(3):283-93. PubMed ID: 16951269
[TBL] [Abstract][Full Text] [Related]
15. Extraskeletal mesenchymal chondrosarcoma of the forearm: a case report.
Anderson JT; Lucas GL
J Hand Surg Am; 2007 Mar; 32(3):389-92. PubMed ID: 17336849
[TBL] [Abstract][Full Text] [Related]
16. [Mesenchymal chondrosarcoma of the lung].
Dubova EA; Mishnev OD; Perepechin VI; Shchegolev AI
Arkh Patol; 2008; 70(3):44-5. PubMed ID: 18727434
[TBL] [Abstract][Full Text] [Related]
17. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms.
Ahrens WA; Ridenour RV; Caron BL; Miller DV; Folpe AL
Hum Pathol; 2008 Oct; 39(10):1519-26. PubMed ID: 18620729
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal chondrosarcoma of the head and neck.
Pellitteri PK; Ferlito A; Fagan JJ; Suárez C; Devaney KO; Rinaldo A
Oral Oncol; 2007 Nov; 43(10):970-5. PubMed ID: 17681487
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
Dantonello TM; Int-Veen C; Leuschner I; Schuck A; Furtwaengler R; Claviez A; Schneider DT; Klingebiel T; Bielack SS; Koscielniak E; ;
Cancer; 2008 Jun; 112(11):2424-31. PubMed ID: 18438777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
